col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


36 Results       Page 1

 [1] 
Elsevier: Journal of Molecular Biology
  original article Date Title Authors   All Authors
1 [GO] 2022―Jul―16 Allosteric hotspots in the main protease of SARS-CoV-2 Léonie Strömich, Nan Wu, Mauricio Barahona, Sophia N. Yaliraki
2 [GO] 2022―Jul―15 Binding adaptation of GS-441524 diversifies macro domains and downregulate SARS-CoV-2 de-MARylation capacity Aikaterini C. Tsika, Angelo Gallo, Nikolaos K. Fourkiotis, Aikaterini I. Argyriou, Sridhar Sreeramulu, Frank Löhr, et al. (+11)
3 [GO] 2022―Jul―07 Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814 Jian Li, Cheng Lin, Xuelan Zhou, Fanglin Zhong, Pei Zeng, Peter J. McCormick, et al. (+2)
4 [GO] 2022―Jun―11 Can machines learn the mutation signatures of SARS-CoV-2 and enable viral-genotype guided predictive prognosis? Sunil Nagpal, Nishal Kumar Pinna, Namrata Pant, Rohan Singh, Divyanshu Srivastava, Sharmila S. Mande
5 [GO] 2022―May―17 An electrostatically-steered conformational selection mechanism promotes SARS-CoV-2 Spike protein variation Marija Sorokina, Jaydeep Belapure, Christian Tüting, Reinhard Paschke, Ioannis Papasotiriou, João Pglm Rodrigues, Panagiotis L. Kastritis
6 [GO] 2022―May―07 Biophysical fitness landscape of the SARS-CoV-2 Delta variant receptor binding domain Casey Patrick, Vaibhav Upadhyay, Alexandra Lucas, Krishna M.G. Mallela
7 [GO] 2022―Apr―09 Development of monoclonal antibodies to detect for SARS-CoV-2 proteins Nawneet Mishra, Joan Teyra, Ruthmabel Boytz, Shane Miersch, Trudy N. Merritt, Lia Cardarelli, et al. (+7)
8 [GO] 2022―Feb―28 SARS-CoV-2 nucleocapsid protein targets a conserved surface groove of the NTF2-like domain of G3BP1 Mahamaya Biswal, Jiuwei Lu, Jikui Song
9 [GO] 2022―Jan―03 Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development Xuesen Zhao, Danying Chen, Xinglin Li, Lauren Griffith, Jinhong Chang, Ping An, Ju-Tao Guo
10 [GO] 2021―Dec―13 Where all the roads meet? A crossover prespective on host factors regulating SARS-CoV-2 infection Sneh Lata, Ritu Mishra, Ravi P. Arya, Pooja Arora, Anismrita Lahon, Akhil C. Banerjea, Vikas Sood
11 [GO] 2021―Nov―12 Disulfide bonds play a critical role in the structure and function of the receptor-binding domain of the SARS-CoV-2 Spike antigen Andrey M. Grishin, Nataliya V. Dolgova, Shelby Landreth, Olivier Fisette, Ingrid J. Pickering, Graham N. George, et al. (+2)
12 [GO] 2021―Oct―28 Allosteric regulation of 3CL protease of SARS-CoV-2 and SARS-CoV observed in the crystal structure ensemble Akinori Kidera, Kei Moritsugu, Toru Ekimoto, Mitsunori Ikeguchi
13 [GO] 2021―Oct―28 Glycosylation and serological reactivity of an expression-enhanced SARS-CoV-2 viral spike mimetic Himanshi Chawla, Sian E. Jossi, Sian E. Faustini, Firdaus Samsudin, Joel D. Allen, Yasunori Watanabe, et al. (+8)
14 [GO] 2021―Oct―01 The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation Maaran Michael Rajah, Annie Bernier, Julian Buchrieser, Olivier Schwartz
15 [GO] 2021―Sep―22 Mechanisms of Antiviral Immune Evasion of SARS-CoV-2 Daniel K Beyer, Adriana Forero
16 [GO] 2021―Sep―03 Inhibition of SARS-CoV-2 infection by human defensin HNP1 and retrocyclin RC-101 Elena Kudryashova, Ashley Zani, Geraldine Vilmen, Amit Sharma, Wuyuan Lu, Jacob S. Yount, Dmitri S. Kudryashov
17 [GO] 2021―Aug―23 An Adverse OutcomesApproach to Study theEffects of SARS-CoV-2 in 3D Organoid Models Amrita Basu, Annapurna Pamreddy, Pragya Singh, Kumar Sharma
18 [GO] 2021―Jul―28 Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations Shane Miersch, Zhijie Li, Reza Saberianfar, Mart Ustav, James Brett Case, Levi Blazer, et al. (+22)
19 [GO] 2021―Jul―14 Revealing the Threat of Emerging SARS-CoV-2 Mutations to Antibody Therapies Jiahui Chen, Kaifu Gao, Rui Wang, Guo-Wei Wei
20 [GO] 2021―Jun―24 A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process G.D. Noske, A.M. Nakamura, V.O. Gawriljuk, R.S. Fernandes, G. M. A. Lima, H. V. D. Rosa, et al. (+9)
21 [GO] 2021―Jun―20 The inherent dynamics and interaction sites of the SARS-CoV-2 nucleocapsid N-terminal region Jasmina S. Redzic, Eunjeong Lee, Alexandra Born, Aaron Issaian, Morkos A. Henen, Parker Nichols, et al. (+5)
22 [GO] 2021―Jun―09 Can we AlphaFold our way out of the next pandemic? Matthew K. Higgins
23 [GO] 2021―May―21 Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants Charlie Laffeber, Kelly de Koning, Roland Kanaar, Joyce HG Lebbink
24 [GO] 2021―May―14 Structural modeling of the SARS-CoV-2 Spike/human ACE2 complex interface can identify high-affinity variants associated with increased transmissibility Hin Hark Gan, Alan Twaddle, Benoit Marchand, Kristin C. Gunsalus
25 [GO] 2021―Apr―22 N-Terminal finger stabilizes the S1 pocket for the reversible feline drug GC376 in the SARS-CoV-2 Mpro dimer Elena Arutyunova, Muhammad Bashir Khan, Conrad Fischer, Jimmy Lu, Tess Lamer, Wayne Vuong, et al. (+6)
26 [GO] 2021―Apr―08 Structure-Based Design of a Specific, Homogeneous Luminescence Enzyme Reporter Assay for SARS-CoV-2 Frederic A. Fellouse, Shane Miersch, Chao Chen, Stephen W. Michnick
27 [GO] 2021―Mar―26 Engineered ultra-high affinity synthetic antibodies for SARS-CoV-2 neutralization and detection Tomasz Slezak, Anthony A. Kossiakoff
28 [GO] 2021―Mar―20 Platforms for Personalized Polytherapeutics Discovery in COVID-19 Chris Hopkins, Chidinma Onweni, Victoria Zambito, DeLisa Fairweather, Kathryn McCormick, Ebihara Hideki, et al. (+3)
29 [GO] 2021―Mar―19 SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca2+ Alex L. Lai, Jack H. Freed
30 [GO] 2021―Feb―05 The mechanism of SARS-CoV-2 nucleocapsid protein recognition by the human 14-3-3 proteins Kristina V. Tugaeva, Dorothy E. D. P. Hawkins, Jake L. R. Smith, Oliver W. Bayfield, De-Sheng Ker, Andrey A. Sysoev, et al. (+3)
31 [GO] 2020―Dec―17 Subtle influence of ACE2 glycan processing on SARS-CoV-2 recognition Joel D. Allen, Yasunori Watanabe, Himanshi Chawla, Maddy L. Newby, Max Crispin
32 [GO] 2020―Dec―11 The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition Takamitsu Hattori, Akiko Koide, Maria G. Noval, Tatyana Panchenko, Larizbeth A. Romero, Kai Wen Teng, et al. (+4)
33 [GO] 2020―Nov―24 Structural insights into SARS-CoV-2 proteins Rimanshee Arya, Shweta Kumari, Bharati Pandey, Hiral Mistry, Subhash C Bihani, Amit Das, et al. (+4)
34 [GO] 2020―Sep―11 Anti-Frameshifting Ligand Active against SARS Coronavirus-2 Is Resistant to Natural Mutations of the Frameshift-Stimulatory Pseudoknot Krishna Neupane, Sneha Munshi, Meng Zhao, Dustin B. Ritchie, Sandaru M. Ileperuma, Michael T. Woodside
35 [GO] 2020―Jul―23 Mutations Strengthened SARS-CoV-2 Infectivity Jiahui Chen, Rui Wang, Menglun Wang, Guo-Wei Wei
36 [GO] 2020―Apr―19 Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop Javier A. Jaimes, Nicole M. André, Joshua S. Chappie, Jean K. Millet, Gary R. Whittaker
 [1] 

36 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec